Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GSK · against 1,335 other Healthcare companies
Ranked #142 of 1,336 · scores higher than 89% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 80–89, including GSK · Click a bar to see the companies
Mainly thanks to its return on assets, operating margin and return on invested capital, which are stronger than most Healthcare peers.
| Metric | GSK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 20.4% | 4.7% | 86% | 33% | |
| Operating marginHigher is better · 1,251 reported | 24.3% | 7.1% | 87% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 9.4% | 1.7% | 89% | 33% | |
| Return on equityHigher is better · 1,252 reported | 33.4% | 3.2% | 95% | Context only | |
| Gross marginHigher is better · 1,394 reported | 73.5% | 45.9% | 81% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 142 | 3.6B CNY (≈$506M) | 89 | 65 | |
| 142 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 31.1B TWD (≈$965M) |
| 89 |
| 63 |
| 142 | 18.3B CNY (≈$2.6B) | 89 | 80 |
| 142 | 111.7B DKK (≈$16.8B) | 89 | 53 |
| 142 | 97.5B USD | 89 | 67 |
| 142 | 36.0B USD | 89 | 46 |
| 142 | 1.3B BRL (≈$238M) | 89 | 77 |
| 142 | 2.2B USD | 89 | 66 |
| 142 | 14.4B USD | 89 | 71 |